Which of the following is an outcome of the FDA's regulatory role?

The impact on companies developing new drugs is a significant outcome of the FDA's regulatory role. The FDA establishes rigorous standards and guidelines that companies must follow to ensure the safety and efficacy of new medications before they can be marketed to the public. This regulatory framework influences the entire development process, from the initial research phase through clinical trials and post-market surveillance.

Pharmaceutical companies must invest considerable time and resources into complying with these regulations to demonstrate that their products meet safety standards and are effective for their intended uses. As a result, the FDA's oversight can drive innovation, push companies to adhere to ethical practices, and ultimately enhance public health by filtering out unsafe or ineffective drugs from the market.

This rigorous vetting process creates a high barrier to entry, ensuring that only those drugs that have undergone thorough testing and evaluation reach consumers, thus protecting public health and safety.